BeiGene (HKG:6160, SHA:688235) reported that its net loss for 2024 narrowed by 26.9% to $644.8 million from the $881.7 million loss a year earlier, according to a Thursday filing with the Hong Kong bourse.
Loss per share narrowed 27.7% to $0.47 from $0.65 loss per share a year ago.
Revenue rose 55.0% to $3.78 billion from $2.19 billion the previous year.
The company's shares were up 1% at the Hong Kong bourse while down less than 1% at the Shanghai bourse in recent trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。